您要查找的是不是：
- Objective:To observe the effect of anti-lymphocyte globulin(ALG)combined with cyclosporin A(CsA)in treatment of severe aplastic anemia(SAA). 目的觀察抗淋巴細胞球蛋白(ALG)和環孢素A(CsA)、雄激素聯合治療重型再生障礙性貧血(SAA)的療效。
- Conclusion ALG/ATG in treatment of severe aplastic anemia was valid and safe.ANC would be a prognostic factor for efficiency in SAA. 結論ALG/ATG作為重要免疫抑製劑治療SAA療效肯定，其相關不良反應可獲得較好控制，而治療前患者外周血ANC可能對療效判斷有提示意義。
- The expression of CyP mRNA of severe aplastic anemia (SAA) and chronic aplastic anemia(CAA)patients remarkably decreased than normal control(P<0.05),whereas,there was no statistical difference between SAA and CAA(P>0.05). 重型再生障礙性貧血(SAA)和慢性再生障礙性貧血(CAA)患者CyP mRNA表達水平分別為1.;70±1
- Bacigalupo A, et al. Severe aplastic anemia immunosup-pression in 20 patients. Br J Haematol, 1981,47:423. 陳琳軍林果為.;環孢黴素A合併雄激素治療成人重型再生障礙性貧血[J]
- Objective To observe the curative effect of the therapy of replenishing qi and blood combined with stanozolol on severe aplastic anemia. 目的觀察益氣養血補腎法治療重型再生障礙性貧血的臨床療效。
- Objective To evaluate the safety measures for children with severe aplastic anemia, treated by the combination of human immunoglobulin and cyclosporin A. 目的探討採用抗人胸腺免疫球蛋白聯合環孢素A治療重型再生障礙性貧血患兒副反應的安全防護措施。
- Of seven patients, 3 were acute leukemia (AL) in first complete remission (CR1), 1 AL in CR2, 1 Myeloid Dysplastic Syndrome (MDS), 1 Severe Severe Aplastic Anemia (SSAA), 1 AA-paroxysmal nocturnal hemoglo-binuria (PNH), 1 non-Hodgkin Lymphoma (NHL). 7例中,急性白血病第1次完全緩解(CR1)3例,CR2 1例,骨髓增生異常綜合征(MDS)1例,極重症再生障礙性貧血(SSAA)1例,再障-陣發性睡眠性血紅蛋白尿(AA-PNH)1例。
- Now,severe aplastic anemia can be effectively treated by bone-marrow transplantation,immune depressive therapy (generally antithymocyte globulin and ciclosporin),and high-dose cyclophosphamide. 目前對重型再生障礙性貧血的有效治療方法主要是骨髓移植、免疫抑制療法(通常是抗胸腺球蛋白和環孢菌素)和大劑量的環磷醯胺。
- he effect of monoclonal antihuman T-cell antibody(McAb-T) on hemopoietic progenitor cells of 19 patientswith severe aplastic anemia (SAA) was observed. 報告抗T淋巴細胞單克隆抗體（McAb－T）對重型再生障礙性貧血（SAA）造血祖細胞的影響。
- Keywords Children;Severe aplastic anemia;ALG;Curative effect; 兒童;重型再生障礙性貧血;ALG;治療效果;
- Progression of haemopoietic stem cell transplantation on severe aplastic anemia 造血幹細胞移植治療重型再生障礙性貧血進展
- Treatment of severe aplastic anemia with high dose globin and male hormone 大劑量丙種球蛋白與雄性激素聯合治療重型再生障礙性貧血
- Intensive Immunosuppressive Therapy for Children with Severe Aplastic Anemia 強化免疫抑制治療兒童再生障礙性貧血療效分析
- Successful unrelated HLA-mismatched cord blood transplantation in a patient with severe aplastic anemia 非親緣HLA不相合臍血移植治療再生障礙性貧血
- Comparison of three regiments with immunosupressors in treatment of severe aplastic anemia 幾種免疫抑製劑聯合方案治療重型再生障礙性貧血的療效比較
- HLA non-identical allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia HLA不全相合異基因外周血幹細胞移植治療重型再生障礙性貧血
- Nursing Care of the Patients with Severe Aplastic Anemia Receiving Antilymphocyte Globulin 抗淋巴細胞球蛋白治療重型再生障礙性貧血的護理
- A primary study on establishing T-cell clones in vitro from bone marrow of a severe aplastic anemia patient 重型再生障礙性貧血患者骨髓T細胞克隆的初步研究
- Clinical Study of ALG/ATG as a Main Regimen of Immunosuppressive Therapy in Treatment of Severe Aplastic Anemia ALG/ATG為主的免疫抑製劑治療重型再生障礙性貧血的臨床研究
- The Observation and Nursing of Rash in Severe Aplastic Anemia Patients Treated with ALG/ ATG ALG/ATG治療重型再生障礙性貧血后血清病皮疹的觀察及護理
